Sort
326,823 grants matching “clinical trial”
NIDA Clinical Trials Network: Greater New York Node
$2,054,565John P Rotrosen · New York University School Of Medicine · UG1 · FY2019 · DA
Substance Abuse Research - Medications Development Center
$2,054,493Joy Marie Schmitz · University Of Texas Hlth Sci Ctr Houston · P50 · FY2014 · DA
Impact of FGF21 on healthspan and lifespan
$2,054,233Vishwa Deep Dixit · Yale University · P01 · FY2016 · AG
Functional Polymorphism Analysis in Drug Pathways
$2,054,116Washington University · U01 · FY2002 · GM
Hormonal Control of Calcium Metabolism
$2,054,112John T Potts · Massachusetts General Hospital · P01 · FY2023 · DK
Hormonal Control of Calcium Metabolism
$2,054,112John T Potts · Massachusetts General Hospital · P01 · FY2022 · DK
Targeted Sphingolipid Metabolism for Treatment of AML
$2,054,089Thomas P Loughran · University Of Virginia · P01 · FY2020 · CA
TUFTS CLINICAL AND TRANSLATION SCIENCE INSTITUTE (UL1)
$2,053,813Harry P Selker · Tufts University Boston · UL1 · FY2011 · RR
CAPRISA Clinical Trials Unit for AIDS/Tuberculosis Prevention and Treatment
$2,053,782Quarraisha Abdool Karim · Centre/Aids Programme/Res/South Africa · UM1 · FY2020 · AI
Computational Pathology Research for Cancer Modeling, Diagnostics and Biomarkers
$2,053,644Robert Simpson · Division Of Basic Sciences - Nci · ZIC · FY2024 · CA
Clinical Implementation of Carrier Testing using NGS
$2,053,375Katrina A Goddard · Kaiser Foundation Research Institute · UM1 · FY2013 · HG
HIV PREVENTION TRIAL UNIT (HPTU)-PUNE, INDIA
$2,053,338Johns Hopkins University · U01 · FY2005 · AI
A Novel Compound for Targeted Treatment of CBF Leukemia
$2,053,144Anton Simeonov · National Center For Advancing Translational Sciences · ZIA · FY2017 · TR
Prevention of AIDS
$2,053,144Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2014 · CA
Early Therapeutics Development with Phase II Emphasis
$2,053,128Charles Erlichman · Mayo Clinic Rochester · N01 · FY2009 · CA
Mental Health Research Network III
$2,052,966Gregory E Simon · Kaiser Foundation Research Institute · U19 · FY2020 · MH
Emory- Duke- Orlando- CDC (EmDOC) Clinical Trials Unit
$2,052,913Jeffrey Lennox · Emory University · UM1 · FY2016 · AI
Immunologic Approaches to Ovarian Cancer
$2,052,807David R Spriggs · Sloan-Kettering Inst Can Research · P01 · FY2015 · CA
Antecedent Biomarkers For AD: The Adult Children Study
$2,052,600John Morris · Washington University · P01 · FY2019 · AG
Philadelphia IMPAACT Clinical Trials Unit
$2,052,385Steven Daniel Douglas · Children'S Hosp Of Philadelphia · U01 · FY2009 · AI
Papillomavirus Virion Proteins and Vaccines
$2,052,333John T. Schiller · Division Of Basic Sciences - Nci · ZIA · FY2018 · CA
Development of Novel Therapeutic Strategies in Human Leukemias
$2,052,164Benjamin Levine Ebert · Dana-Farber Cancer Inst · P01 · FY2025 · CA
SPORE: Dana-Farber/Harvard Cancer Center SPORE in Breast Cancer
$2,051,965Eric P Winer · Dana-Farber Cancer Inst · P50 · FY2017 · CA
Brain Tumor Clinical and Clinical Research Program
$2,051,617Howard Fine · Division Of Basic Sciences - Nci · Z01 · FY2008 · CA
Diverse Strategies to Correct the Dystrophin Gene Using Vascular Delivery (U54)
$2,051,556Jerry Mendell · Research Inst Nationwide Children'S Hosp · U54 · FY2008 · NS